PALVELLA THERAPEUTICS, INC. - Common Stock, $0.01 par value (PVLA)
CUSIP: 697947109
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, $0.01 par value
- Shares outstanding
- 11,842,870
- Total 13F shares
- 9,759,838
- Share change
- +1,147,526
- Total reported value
- $1,021,544,191
- Put/Call ratio
- 51%
- Price per share
- $104.67
- Number of holders
- 141
- Value change
- +$142,062,451
- Number of buys
- 94
- Number of sells
- 40
Quarterly Holders Quick Answers
What is CUSIP 697947109?
CUSIP 697947109 identifies PVLA - PALVELLA THERAPEUTICS, INC. - Common Stock, $0.01 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 697947109:
Top shareholders of PVLA - PALVELLA THERAPEUTICS, INC. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| First Light Asset Management, LLC |
13D/G
13F
|
Company |
7.5%
|
887,031
|
$89,137,745 | $0 | 31 Dec 2025 | |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
|
BVF PARTNERS L P/IL |
7.1%
|
879,009
|
$88,331,614 | -$30,366,571 | 31 Dec 2025 | |
| BVF INC/IL |
13F
|
Company |
9.8%
|
1,161,249
|
$72,798,700 | — | 30 Sep 2025 | |
| Frazier Life Sciences Public Fund, L.P. |
13D/G
|
— |
6%
|
706,360
|
$70,982,116 | +$16,164,419 | 31 Dec 2025 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13D/G
13F
|
Company |
7.4%
|
822,400
|
$51,556,256 | +$6,766,571 | 30 Sep 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
6.1%
|
722,400
|
$45,287,256 | — | 30 Sep 2025 | |
| Kaupinen Wes |
13D/G
|
— |
15%
|
1,644,869
|
$38,555,729 | $0 | 13 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.2%
|
494,656
|
$31,009,985 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
4.1%
|
487,616
|
$30,568,649 | — | 30 Sep 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.3%
|
395,093
|
$24,768,380 | — | 30 Sep 2025 | |
| Woodline Partners LP |
13F
|
Company |
2.9%
|
345,749
|
$21,675,005 | — | 30 Sep 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
2.9%
|
339,047
|
$21,254,856 | — | 30 Sep 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.7%
|
317,309
|
$19,892,125 | — | 30 Sep 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
2.1%
|
250,062
|
$15,676,387 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2%
|
236,630
|
$14,834,334 | — | 30 Sep 2025 | |
| Samsara BioCapital, LLC |
13F
|
Company |
1.8%
|
209,634
|
$13,141,955 | — | 30 Sep 2025 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
186,751
|
$11,707,420 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
168,110
|
$10,541,344 | — | 30 Sep 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1.4%
|
166,535
|
$10,440,079 | — | 30 Sep 2025 | |
| Samsara BioCapital, L.P. |
13D/G
|
— |
3.1%
|
339,743
|
$8,989,600 | -$8,989,600 | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
138,505
|
$8,682,877 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.2%
|
137,251
|
$8,604,265 | — | 30 Sep 2025 | |
| FMR LLC |
13F
|
Company |
0.93%
|
110,446
|
$6,923,860 | — | 30 Sep 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.9%
|
106,910
|
$6,702,187 | — | 30 Sep 2025 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
0.8%
|
95,259
|
$5,971,787 | — | 30 Sep 2025 | |
| Clio Asset Management LLC |
13F
|
Company |
0.77%
|
91,641
|
$5,744,974 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.76%
|
89,697
|
$5,623,105 | — | 30 Sep 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.59%
|
69,416
|
$4,351,689 | — | 30 Sep 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
0.57%
|
67,423
|
$4,226,748 | — | 30 Sep 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.55%
|
64,746
|
$4,058,926 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.46%
|
54,003
|
$3,385,449 | — | 30 Sep 2025 | |
| Dellora Investments LP |
13D/G
3/4/5
|
no longer 10% owner |
1.3%
|
141,079
|
$3,306,892 | $0 | 13 Dec 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.43%
|
51,243
|
$3,212,424 | — | 30 Sep 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.42%
|
49,509
|
$3,103,719 | — | 30 Sep 2025 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.41%
|
49,115
|
$3,079,019 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.41%
|
48,610
|
$3,047,361 | — | 30 Sep 2025 | |
| J. Goldman & Co LP |
13F
|
Company |
0.34%
|
40,692
|
$2,550,981 | — | 30 Sep 2025 | |
| ADAR1 Capital Management, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
144,641
|
$2,297,246 | — | 09 Aug 2024 | |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC |
13F
|
Company |
0.29%
|
34,895
|
$2,187,568 | — | 30 Sep 2025 | |
| Todd C. Davis |
3/4/5
|
Director |
—
mixed-class rows
|
149,597
mixed-class rows
|
$1,787,516 | — | 10 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.23%
|
26,874
|
$1,684,731 | — | 30 Sep 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.22%
|
25,532
|
$1,600,601 | — | 30 Sep 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.2%
|
23,838
|
$1,494,403 | — | 30 Sep 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.2%
|
23,702
|
$1,485,878 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.18%
|
21,013
|
$1,317,305 | — | 30 Sep 2025 | |
| Mariner, LLC |
13F
|
Company |
0.17%
|
20,722
|
$1,299,062 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.17%
|
20,439
|
$1,281,320 | — | 30 Sep 2025 | |
| Cresset Asset Management, LLC |
13F
|
Company |
0.15%
|
17,424
|
$1,092,311 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
16,185
|
$1,014,638 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.11%
|
12,705
|
$796,477 | — | 30 Sep 2025 |
Institutional Holders of PALVELLA THERAPEUTICS, INC. - Common Stock, $0.01 par value (PVLA) as of Q4 2025
As of 31 Dec 2025,
PALVELLA THERAPEUTICS, INC. - Common Stock, $0.01 par value (PVLA) was held by
141 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,759,838 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, BVF INC/IL, Frazier Life Sciences Management, L.P., First Light Asset Management, LLC, VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC, JENNISON ASSOCIATES LLC, and FEDERATED HERMES, INC..
This page lists
141
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
100
Q4 2025 holders
141
Holder diff
41
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.